FRENOLYN Inhalation powder Ref.[28222] Active ingredients: Budesonide

Source: Υπουργείο Υγείας (CY)  Revision Year: 2017  Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus

Product name and form

Frenolyn 200 micrograms inhalation powder.

Pharmaceutical Form

Inhalation powder.

Breath actuated metered dose dry powder, administrated with a Miat–Haler device.

The device, Miat–Haler, consists of a light grey body with a dark brown screw closure, that when opened shows a light grey inhaler.

Qualitative and quantitative composition

Budesonide.

Each metered dose contains 200 micrograms of budesonide.

Excipient with known effect: lactose monohydrate. Each metered dose contains 2300 micrograms of lactose monohydrate.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Budesonide

Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.

List of Excipients

Frenolyn also contains lactose monohydrate.

Pack sizes and marketing

Miat–Haler:

Polypropylene container consisting of a brown screw cap and a grey case. Removal of the cap reveals the body of the inhaler, consisting of a polyacetal (POM) mouthpiece, acrilonitrile butadiene styrene (ABS) body, a polybutylene terephthalate (PBT) dosing mechanism, and the immediate drug container made of methacrylate butadiene styrene (MABS) and sealed with a low density polyethylene (LDPE) stopper.

The grey case also contains a desiccant pill, with a symbol indicating not for oral ingestion. This should not be removed.

Each Miat–Haler is packed into a polyester – aluminium – polyethylene strip, and packaged, with a patient information leaflet, in a card carton.

Miat–Haler budesonide 200 is available in devices with 100 doses, or 200 doses.

Cartons containing one inhaler, or three inhalers are available.

Not all pack sizes may be marketed.

Marketing authorization holder

MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus

Marketing authorization dates and numbers

20291

29.01.2008 / 02.02.2015

Drugs

Drug Countries
FRENOLYN Cyprus, Malta, Romania, Singapore

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.